🇺🇸 FDA
Patent

US 9974853

Immunoregulatory peptides and methods of use

granted A61KA61K38/00A61K39/285

Quick answer

US patent 9974853 (Immunoregulatory peptides and methods of use) held by Compass Therapeutics LLC expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/00, A61K39/285, A61P, A61P1/10